American Diabetes Association

When the chief executive of the world’s most valuable obesity-drug company admits he’s surprised that a diabetes conference…

Key Points “The field is getting more crowded — but Lilly is widening its lead,” said RBC analyst…

For Novo Nordisk, the launch of the company’s highly anticipated Wegovy pill at the start of the year—representing…

Novo Nordisk A/S (NYSE:NVO) is one of the 7 Best Longevity Stocks to Buy Now. On June 7,…

Novo Nordisk (NYSE:NVO) is one of the top large cap value stocks to buy now. On June 8,…

Even as industry watchers pit the two obesity assets against one another, it’s too early to say whose…

chart down red arrow NEW SIZE ©Shutterstock Novo Nordisk (NYSE:NVO) shares fell 3% on Monday as investors digested…

Plainsboro: Novo Nordisk’s next-generation weight-loss candidate, zenagamtide has delivered an average weight-loss of up to 14.6 per cent…

PLAINSBORO, N.J. and BAGSVÆRD, Denmark, June 7, 2026 /PRNewswire/ — Novo Nordisk today announced Wegovy® (semaglutide) tablets 25…

Post hoc analyses explored the impact of semaglutide across an array of conditions including obstructive sleep apnea (OSA),…

We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Novo Nordisk A/S…

Novo Nordisk faces new GLP-1 rival as Eli Lilly’s triple agonist sets weight-loss record Proactive uses images sourced…

Novo Nordisk CEO Dustar: Obesity Has Eclipsed Diabetes at ADA as Lilly’s Retatrutide Hits 28.3% Weight Loss — BigGo Finance